Dynamics of procalcitonin and bacteremia in neutropenic adults with acute myeloid leukemia

Leukemia Research

Volumn 35, Issue 10, 2011, Pages 1294-1296

  Gac, Anne Claire ^a   Parienti, Jean Jacques ^a   Chantepie, Sylvain ^a   Fradin, Sabine ^a   Le Coutour, Xavier ^a   Leclercq, Roland ^a   Reman, Oumedaly ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Acute myeloid leukemia; Bacteremia; Procalcitonin

Indexed keywords

AMIKACIN; CEFTRIAXONE; PROCALCITONIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEMALE; HUMAN; IMMUNOASSAY; KLEBSIELLA PNEUMONIAE; MALE; MOLECULAR DYNAMICS; PREDICTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; TREATMENT PLANNING;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BACTEREMIA; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; NEUTROPENIA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 80052089421     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.05.035     Document Type: Article

References (14)

1. Simon L., Gauvin F., Amre D.K., Saint-Louis P., Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004, 39(2):206-217.
2. Svaldi M., Hirber J., Lanthaler A.I., Mayr O., Faes S., Peer E., et al. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 2001, 115(1):53-57.
3. Sakr Y., Sponholz C., Tuche F., Brunkhorst F., Reinhart K. The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection 2008, 36(5):396-407.
4. Fleischhack G., Cipic D., Juettner J., Hasan C., Bode U. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer. Intensive Care Med 2000, 26(Suppl. 2):S202-S211.
5. Ascioglu S., Rex J.H., de Pauw B., Bennett J.E., Bille J., Crokaert F., et al. Defining opportunistic invasive fungal infections in immuno compromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34(1):7-14.
6. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101(6):1644-1655.
7. Sarmati L., Beltrame A., Dori L., Maffongelli G., Cudillo L., De Angelis G., et al. Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis. Am J Hematol 2010, 85(5):380-383.
8. De Bont E.S., Vellenga E., Swaanenburg J., Kamps W. Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever?. Infection 2000, 28(6):398-400.
9. Giamarellou H., Giamarellos-Bourboulis E.J., Repoussis P., Galani L., Anagnostopoulos N., Grecka P., et al. Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin Microbiol Infect 2004, 10(7):628-633.
10. Persson L., Engervall P., Magnuson A., Vikerfors T., Soderquist B., Hansson L.O., et al. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis 2004, 36(5):365-371.
11. Maruna P., Frasko R., Gurlich R. Plasma procalcitonin in patients with ileus. Relations to other inflammatory parameters. Physiol Res 2008, 57(3):481-486.
12. Nijsten M.W., Olinga P., The T.H., de Vries E.G., Koops H.S., Groothuis G.M., et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000, 28(2):458-461.
13. Oberhoffer M., Stonans I., Russwurm S., Stonane E., Vogelsang H., Junker U., et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999, 134(1):49-55.
14. Ortega M., Rovira M., Filella X., Martinez J.A., Almela M., Puig J., et al. Prospective evaluation of procalcitonin in adults with non-neutropenic fever after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006, 37(5):499-502.